Insulet Quarterly Balance Sheet
NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insulet financial position
As of Jun 30, 2026, Insulet reported total assets of $3.17 billion, down 8.8% from a year earlier against total liabilities of $1.74 billion. Shareholders' equity stood at $1.42 billion, or 44.9% of assets. The company held $534.9 million in cash and equivalents against $948.4 million of debt, a net debt position of $413.5 million.
The current ratio (current assets divided by current liabilities) was 2.48, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.67.
Summary generated from market data by MetaCap's automated system. Methodology
Insulet balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 534.90M | 480.40M | 716.10M | 757.40M | 1.12B | 1.28B | 953.40M | 902.60M | 821.00M | 751.20M | 704.20M | 685.40M |
| Receivables | 588.70M | 544.70M | 516.90M | — | — | — | — | — | — | — | — | — |
| Inventory | 484.80M | 462.50M | 452.60M | 446.30M | 446.90M | 440.80M | 430.40M | 444.90M | 430.90M | 430.60M | 402.60M | 410.80M |
| Total Current Assets | 1.85B | 1.71B | 1.91B | 1.86B | 2.28B | 2.33B | 1.89B | 1.86B | 1.75B | 1.62B | 1.58B | 1.47B |
| Property, Plant & Equipment | 858.60M | 830.40M | 819.50M | 724.10M | 720.40M | 718.70M | 723.10M | 702.90M | 677.90M | 667.70M | 664.90M | 649.20M |
| Goodwill | 51.60M | 51.60M | 51.60M | 51.60M | 51.70M | 51.50M | 51.50M | 51.70M | 51.70M | 51.70M | 51.70M | 51.70M |
| Intangible Assets | 115.10M | 115.20M | 117.10M | 105.00M | 102.30M | 99.80M | 98.50M | 99.60M | 98.50M | 98.50M | 98.70M | 99.50M |
| Total Assets | 3.17B | 2.99B | 3.19B | 3.03B | 3.47B | 3.52B | 3.09B | 3.03B | 2.88B | 2.62B | 2.59B | 2.47B |
| Accounts Payable | 123.30M | 149.80M | 75.00M | 48.20M | 96.10M | 57.60M | 19.80M | 40.30M | 76.80M | 75.90M | 19.20M | 77.80M |
| Short-Term Debt | 18.90M | 18.60M | 18.40M | 79.90M | 460.70M | 83.10M | 83.80M | 42.00M | 37.90M | 38.90M | 49.40M | 49.80M |
| Total Current Liabilities | 744.20M | 687.50M | 680.10M | 647.70M | 1.01B | 520.40M | 528.40M | 506.20M | 486.00M | 432.40M | 451.20M | 451.40M |
| Long-Term Debt | 929.50M | 929.50M | 930.80M | 934.90M | 939.00M | 1.61B | 1.30B | 1.36B | 1.36B | 1.36B | 1.37B | 1.37B |
| Total Liabilities | 1.74B | 1.68B | 1.68B | 1.65B | 2.01B | 2.19B | 1.88B | 1.91B | 1.88B | 1.83B | 1.86B | 1.86B |
| Shareholders' Equity | 1.42B | 1.30B | 1.52B | 1.38B | 1.46B | 1.33B | 1.21B | 1.12B | 998.40M | 790.70M | 732.70M | 607.50M |
| Retained Earnings | 473.50M | 378.50M | 287.40M | 185.80M | 98.20M | 75.70M | 40.30M | -60.40M | -137.90M | -326.50M | -378.00M | -481.30M |
| Total Debt | 948.40M | 948.10M | 949.20M | 1.01B | 1.40B | 1.70B | 1.38B | 1.40B | 1.40B | 1.40B | 1.42B | 1.42B |
| Net Cash (Debt) | -413.50M | -467.70M | -233.10M | -257.40M | -278.10M | -412.30M | -426.50M | -495.70M | -576.80M | -650.30M | -711.60M | -735.00M |
| Shares Outstanding | — | — | 70.39M | — | — | 70.36M | 70.20M | 70.14M | 70.11M | 70.02M | 69.91M | 69.83M |
This table shows 12 quarterly periods of Insulet's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PODD's reporting calendar. What is a balance sheet?